Moderna Inc

NASDAQ:MRNA   3:59:55 PM EDT
201.52
-5.89 (-2.84%)
4:41:31 PM EDT: $201.10 -0.42 (-0.21%)
Products, Strategic Combinations

Moderna And South Korea Explore Collaboration On mRNA Vaccines

Published: 05/22/2021 15:37 GMT
Moderna Inc (MRNA) - Moderna and South Korea Explore Collaboration on Mrna Vaccines.
Moderna - Announced Two Memoranda of Understanding (mou) With the Government of South Korea.
Moderna - One Mou With Knih, for a New Collaboration on Mrna Vaccine Research in South Korea.
Moderna - an Additional Mou With Motie, Mohw to Explore Local Manufacturing Opportunities for Mrna Vaccines in South Korea.
Moderna - Mous Were Signed Today by Kwon Junwook, Director, Knih and StÉphane Bancel, Moderna’s CEO at Signing Ceremony in Washington, Dcmoderna - With These Mous, Moderna and the Knih Will Explore Areas of Collaboration for Scientific Research on Mrna Vaccines.
Moderna - These Mous May Also Facilitate Discussions Between Moderna,south Korea for Potential Manufacturing Facility for Mrna Vaccines in South Korea.
Moderna - Co and Samsung Biologics Have Entered Into a Manufacturing Services and Supply Agreement.
Moderna-under Agreement, Samsung Biologics in South Korea Will Provide Large Scale, Commercial Fill-finish Manufacturing for Covid-19 Vaccine Moderna.
Mfds Approved Moderna’s Application for Conditional Marketing Authorization for Moderna’s Covid-19 Vaccine on May 21.
Moderna - Gc Pharma in South Korea is the Company’s Marketing Authorization Holder and Distributor of Moderna’s Covid-19 Vaccine for South Korea.
Moderna - South Korea Has Secured Access to 40 Million Doses of Covid-19 Vaccine Moderna.